Sign Up
Stories
Avicanna Launches CBD Oral Formulation
Share
Arizona Senate Approves Psilocybin Cente...
Arizona's Psilocybin Research Grant Open...
Biden's Marijuana Reclassification Initi...
Aelis Farma's 2024 Financial Calendar
Arizona Psilocybin Research Grant
Tilray's Beverage Acquisitions
Overview
API
Avicanna Inc. launches RHO Phyto Micro Drop 100, a CBD oral formulation in Canada, aiming to improve cannabinoid absorption. The company's Trunerox™ received drug approval in Colombia for severe seizures. Avicanna plans a Medical Symposium on cannabinoid-based medicine in Canada.
Ask a question
How does the inverted emulsion technology used in RHO Phyto Micro Drop 100 enhance cannabinoid absorption?
How might Avicanna's Medical Symposium contribute to advancements in cannabinoid-based medicine?
What impact might Avicanna's CBD oral formulation have on the medical cannabis market in Canada?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Coverage